These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 9033274)
1. Immunological evidence for hypochlorite-modified proteins in human kidney. Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274 [TBL] [Abstract][Full Text] [Related]
2. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973 [TBL] [Abstract][Full Text] [Related]
4. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Porubsky S; Schmid H; Bonrouhi M; Kretzler M; Malle E; Nelson PJ; Gröne HJ Am J Pathol; 2004 Jun; 164(6):2175-87. PubMed ID: 15161651 [TBL] [Abstract][Full Text] [Related]
5. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol. Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131 [TBL] [Abstract][Full Text] [Related]
6. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Hazell LJ; Davies MJ; Stocker R Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584 [TBL] [Abstract][Full Text] [Related]
7. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Gröne HJ; Gröne EF; Malle E Lab Invest; 2002 Jan; 82(1):5-14. PubMed ID: 11796821 [TBL] [Abstract][Full Text] [Related]
9. Hypochlorous acid and human blood low density lipoproteins modified by hypochlorous acid increase erythrocyte adhesion to endothelial cells. Gorbatenkova EA; Artmann GM; Panasenko OM Membr Cell Biol; 2000; 13(4):537-46. PubMed ID: 10926371 [TBL] [Abstract][Full Text] [Related]
11. Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study. Zouaoui Boudjeltia K; Roumeguere T; Delree P; Moguilevsky N; Ducobu J; Vanhaeverbeek M; Wespes E Eur Urol; 2007 Jan; 51(1):262-8; discussion 268-9. PubMed ID: 17007997 [TBL] [Abstract][Full Text] [Related]
12. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Spickett CM; Jerlich A; Panasenko OM; Arnhold J; Pitt AR; Stelmaszyńska T; Schaur RJ Acta Biochim Pol; 2000; 47(4):889-99. PubMed ID: 11996112 [TBL] [Abstract][Full Text] [Related]
13. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase. Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568 [TBL] [Abstract][Full Text] [Related]
14. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159 [TBL] [Abstract][Full Text] [Related]
15. Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C. Carr AC; Frei B Biol Chem; 2002; 383(3-4):627-36. PubMed ID: 12033452 [TBL] [Abstract][Full Text] [Related]
16. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis. Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363 [TBL] [Abstract][Full Text] [Related]
17. Effects of hypochlorite-modified low-density and high-density lipoproteins on intracellular Ca2+ and plasma membrane Ca(2+)-ATPase activity of human platelets. Zabe M; Feltzer RE; Malle E; Sattler W; Dean WL Cell Calcium; 1999 Dec; 26(6):281-7. PubMed ID: 10668566 [TBL] [Abstract][Full Text] [Related]
18. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Sakata N; Moh A; Takebayashi S Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198 [TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Sampson JB; Ye Y; Rosen H; Beckman JS Arch Biochem Biophys; 1998 Aug; 356(2):207-13. PubMed ID: 9705211 [TBL] [Abstract][Full Text] [Related]
20. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification. Kapiotis S; Jirovetz L; Hermann M; Laggner H; Exner M; Esterbauer H; Gmeiner BM Biochimie; 2006 Jul; 88(7):785-91. PubMed ID: 16488068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]